Chemplast Sanmar Limited (NSE:CHEMPLASTS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Shareholders of Chemplast Sanmar Limited (NSE:CHEMPLASTS) will be pleased this week, given that the stock price is up 11% to ₹430 following its latest full-year results. Revenues were in line with expectations, at ₹44b, while statutory losses ballooned to ₹6.92 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After the latest results, the four analysts covering Chemplast Sanmar are now predicting revenues of ₹53.1b in 2026. If met, this would reflect a major 21% improvement in revenue compared to the last 12 months. Chemplast Sanmar is also expected to turn profitable, with statutory earnings of ₹9.00 per share. In the lead-up to this report, the analysts had been modelling revenues of ₹52.0b and earnings per share (EPS) of ₹19.30 in 2026. While next year's revenue estimates increased, there was also a large cut to EPS expectations, suggesting the consensus has a bit of a mixed view of these results.

Check out our latest analysis for Chemplast Sanmar

There's been no major changes to the price target of ₹516, suggesting that the impact of higher forecast revenue and lower earnings won't result in a meaningful change to the business' valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Chemplast Sanmar at ₹568 per share, while the most bearish prices it at ₹455. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Chemplast Sanmar's growth to accelerate, with the forecast 21% annualised growth to the end of 2026 ranking favourably alongside historical growth of 2.2% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 13% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Chemplast Sanmar to grow faster than the wider industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Chemplast Sanmar. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. The consensus price target held steady at ₹516, with the latest estimates not enough to have an impact on their price targets.

With that in mind, we wouldn't be too quick to come to a conclusion on Chemplast Sanmar. Long-term earnings power is much more important than next year's profits. We have forecasts for Chemplast Sanmar going out to 2028, and you can see them free on our platform here.

You should always think about risks though. Case in point, we've spotted 1 warning sign for Chemplast Sanmar you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.